Acadia Pharmaceuticals Inc. is rated a Buy for its steady NUPLAZID/DAYBUE franchises & pipeline-driven upside potential. Read more on ACAD stock here.
In its latest PFDD installment, the FDA offers a detailed roadmap for sponsors seeking to design, adapt, or validate COAs that accurately ...
Min Son of Hanol IP & Law explains how a ruling has rejected attempts to limit protection to initially approved drug ...
President Donald Trump has a new opportunity to secure intellectual property victories in the upcoming U.S.-Mexico-Canada ...
Figuring out the best iPad for you can be a little tricky. Apple now sells three different 11-inch tablets and two 13-inch models, each with key differences in pricing, specs and accessory support.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback